miR‐205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling

The onset of secondary resistance represents a major limitation to long‐term efficacy of target therapies in cancer patients. Thus, the identification of mechanisms mediating secondary resistance is the key to the rational design of therapeutic strategies for resistant patients. MiRNA profiling comb...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:EMBO Mol Med
Autores principales: Migliore, Cristina, Morando, Elena, Ghiso, Elena, Anastasi, Sergio, Leoni, Vera P, Apicella, Maria, Cora', Davide, Sapino, Anna, Pietrantonio, Filippo, De Braud, Filippo, Columbano, Amedeo, Segatto, Oreste, Giordano, Silvia
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6127885/
https://ncbi.nlm.nih.gov/pubmed/30021798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201708746
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares